Loading...
Biotech Laboratories (pty) Ltd — Glibenclamide Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #7 buyer for Glibenclamide · $81.1K import value · 9 shipments · SOUTH AFRICA · DGFT Verified
Biotech Laboratories (pty) Ltd is the #7 importer of Glibenclamide from India with $81.1K in import value and 9 verified shipments. Biotech Laboratories (pty) Ltd holds a 0.2% market share in Glibenclamide imports based in SOUTH AFRICA. Overall, Biotech Laboratories (pty) Ltd imports 5 pharmaceutical products worth $4.8M across 4 therapeutic categories.
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MEDOPHARM | $420.3K | 48 | 12 |
| M. J. BIOPHARM PRIVATE LIMITED | $375.5K | 10 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | $274.9K | 9 | 1 |
| CIPLA LIMITED | $235.1K | 27 | 1 |
| CAPLIN POINT LABORATORIES LIMITED | $169.2K | 17 | 5 |
| LINCOLN PHARMACEUTICALS LTD | $124.9K | 16 | 5 |
| ZYDUS LIFESCIENCES LIMITED | $116.0K | 22 | 5 |
| MEDICAMEN BIOTECH LIMITED | $110.9K | 11 | 8 |
| RUSAN PHARMA LIMITED | $107.8K | 3 | 1 |
| S KANT HEALTHCARE LIMITED | $104.7K | 12 | 4 |
India's top Glibenclamide suppliers include MEDOPHARM, M. J. BIOPHARM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED. These companies represent the primary source of Glibenclamide exports from India, serving buyers like Biotech Laboratories (pty) Ltd in SOUTH AFRICA and other global markets.
Buyers ranked immediately above and below #7 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | A,BAUR & CO,(PVT,) LTD | SRI LANKA | $100.0K | 2 | $50.0K |
| 5 | PJSC "PHARMSTANDARD-TOMSKHIMPHARM" | RUSSIA | $100.0K | 2 | $50.0K |
| 7 | BIOTECH LABORATORIES (PTY) LTD ★ | SOUTH AFRICA | $81.1K | 9 | $9.0K |
| 8 | OETHMAAN BIOSIMS PTY LTD | SOUTH AFRICA | $69.2K | 5 | $13.8K |
What Biotech Laboratories (pty) Ltd and other importers must comply with to import Glibenclamide from India
South African Health Products Regulatory Authority (SAHPRA)
Registration of generic medicines under SAHPRA guidelines based on CTD format. Bioequivalence required for generic applications.
Typical timeline: 24–48 months (significant backlog)
WHO GMP or PIC/S GMP compliance; SAHPRA may conduct overseas inspection
India exported $1.3M worth of Glibenclamide through 930 shipments from 194 suppliers to 100 countries, serving 335 buyers globally. Biotech Laboratories (pty) Ltd imports $81.1K of this total, accounting for 0.2% of India's Glibenclamide exports with 9 shipments from SOUTH AFRICA.
Biotech Laboratories (pty) Ltd's average Glibenclamide order value is $9.0K per consignment, based on 9 shipments totaling $81.1K. Biotech Laboratories (pty) Ltd is based in SOUTH AFRICA and ranks #7 among all Glibenclamide importers from India by value.
Top Indian Glibenclamide suppliers include MEDOPHARM ($420.3K), M. J. BIOPHARM PRIVATE LIMITED ($375.5K), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($274.9K), CIPLA LIMITED ($235.1K), CAPLIN POINT LABORATORIES LIMITED ($169.2K). These companies represent the primary source of Glibenclamide exports from India.
Biotech Laboratories (pty) Ltd ranks #7 among 335 Glibenclamide importers from India with a 0.2% market share. The top 3 importers are PJSC PHARMSTANDARD-TOMSKHIMPHARM ($183.7K), OPHAM ($181.8K), M/S. IMRES ($142.4K). Biotech Laboratories (pty) Ltd processed 9 shipments from SOUTH AFRICA.
Biotech Laboratories (pty) Ltd imports 5 products worth $4.8M. Beyond Glibenclamide, top products include Azithromycin, Metronidazole, Enalapril, Nifedipine. View the complete Biotech Laboratories (pty) Ltd profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Glibenclamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for Biotech Laboratories (pty) Ltd's Glibenclamide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Biotech Laboratories (pty) Ltd
Full Company Profile →
5 products · $4.8M total trade · 4 categories
| 9 |
| XXTHMXXN BXXSIMXXPTYXXTD |
| SOUTH AFRICA |
| $61.5K |
| 2 |
| $30.7K |
Biotech Laboratories (pty) Ltd ranks #7 among 335 Glibenclamide importers from India. Average shipment value of $9.0K compared to the market average of $3.7K. The closest competitors by value are A,BAUR & CO,(PVT,) LTD and PJSC "PHARMSTANDARD-TOMSKHIMPHARM".
Import permit from SAHPRA per Section 22A of the Medicines Act
English language labeling; SAHPRA scheduling status displayed
Note: SAHPRA has a known registration backlog. WHO Prequalification of the product or PIC/S certification of the site significantly assists the process.
Regulatory information is provided for general reference based on publicly available SAHPRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with SAHPRA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 335+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for Biotech Laboratories (pty) Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Glibenclamide. For current order-level data, contact TransData Nexus.